Therapy of X-linked adrenoleukodystrophy.

@article{Semmler2008TherapyOX,
  title={Therapy of X-linked adrenoleukodystrophy.},
  author={Alexander Semmler and Wolfgang R. K{\"o}hler and Hans H. Jung and Michael Weller and Michael Linnebank},
  journal={Expert review of neurotherapeutics},
  year={2008},
  volume={8 9},
  pages={1367-79}
}
X-linked adrenoleukodystrophy (X-ALD; OMIM #300100) is caused by defects of the ABCD1 gene on chromosome Xq28, resulting in an impairment of peroxisomal beta-oxidation and the accumulation of saturated very long chain fatty acids (VLCFAs). Primary manifestations occur in the CNS, the adrenal cortex and the testes' Leydig cells. The clinical presentation shows a marked variability which is not explained by the different X-ALD genotypes. Phenotypes range from rapidly progressive cerebral disease… CONTINUE READING
16 Citations
103 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 103 references

Toxic effects of X - linked adrenoleukodystrophyassociated , very long chain fatty acids on glial cells and neurons from rat hippocampus in culture

  • P Schonfeld, S Kahlert, G Reiser
  • Hum . Mol . Genet .
  • 2008

Similar Papers

Loading similar papers…